The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.
about
Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Technology for Innovation in Radiation OncologyPatterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLCDose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.A data-mining framework for large scale analysis of dose-outcome relationships in a database of irradiated head and neck cancer patients.Heart irradiation as a risk factor for radiation pneumonitis.Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols.Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors.Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapyThe prognostic value of irradiated lung volumes on the prediction of intra-/ post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study.Early experience of helical tomotherapy for hepatobiliary radiotherapyEsophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery.Personalized radiotherapy: concepts, biomarkers and trial designIdentifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivorsDelineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancerSTROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics.Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain.Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies.Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.Dose to organs at risk in the upper abdomen in patients treated with extended fields by helical tomotherapy: a dosimetric and clinical preliminary study.Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer.Nonsurgical treatment for localized hepatocellular carcinoma.Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes.Volume Modulated Arc Therapy (VMAT) for pulmonary Stereotactic Body Radiotherapy (SBRT) in patients with lesions in close approximation to the chest wall.Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework.Prescribed dose versus calculated dose of spinal cord in standard head and neck irradiation assessed by 3-D plan.(Radio)biological optimization of external-beam radiotherapy.Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.Advancing our quantitative understanding of radiotherapy normal tissue morbidity.Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.A simple plan evaluation index based on the dose to critical structures in radiotherapy.Dosimetric impact of different multileaf collimators on prostate intensity modulated treatment planning.Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow.Comparative study of four advanced 3d-conformal radiation therapy treatment planning techniques for head and neck cancer.Vision 20/20: Automation and advanced computing in clinical radiation oncology.Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer.Helical tomotherapy for inoperable breast cancer: a new promising tool.Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning?
P2860
Q26774847-BF81078A-D870-4C59-8E1F-A78FE96944D2Q28610710-4B192202-499F-4B8F-A42F-4678C37ACCACQ29248453-439BD96A-2A8A-415E-B9FC-0085DFBB49B4Q30421587-64B079A1-3082-448E-959D-34A63BDD2362Q30978160-F139271C-BBB9-4B75-8EE3-E29E92E199BFQ33698930-BBE7E267-2898-4C21-8B65-D8D2BB794C55Q34211377-86F9A406-2CC9-45BE-9A18-11779B1DCCD5Q34258742-436E7E8D-0500-4D26-95D8-37FFF30E8DBFQ34623353-A0B2A116-6A24-4172-808D-EEAA1A8273EEQ34771688-0DE45973-2938-4C73-9385-5575D5947739Q35051265-11997CDA-2BDD-44D5-AAB2-1E9F11573810Q35545055-69E085CC-ACE7-4B45-8C90-0C39317466B9Q36084206-33D6B57A-25B4-4BDE-9C47-146251353E2EQ36235704-6E9F7497-F8B9-476D-9C91-58EFBED67E5AQ36270141-3E33BA89-7FB3-41D1-B86F-852A1B4EF7C0Q36617872-00B8C022-CF75-4F82-823D-9CC97AD3B2A5Q36672778-73CFF4A6-79DF-4A6B-B82D-48B707CD8083Q36835988-A6FD342C-A673-4CDB-9920-92DDB8E80F60Q36949855-93386D22-A69F-45B3-8D26-3350E4154257Q37016941-A73D96B1-0C43-4B96-BA3D-BF21940A598CQ37037949-37CCE04E-2F01-43BC-B193-FA564BA92C6BQ37277097-BC789DC2-A64B-43E2-A5F5-509C55DF40D0Q37317610-A09B1A46-3164-4283-BD2B-AD0FD45C9319Q37578521-75EE8A16-7FBE-4E5A-8988-DEC53D458D0FQ37663082-332E602C-37B7-41DF-9B22-35211D6E7FB8Q38084619-FDDB590A-8218-4398-B399-54B6ABCB0E96Q38262810-49BFA759-D08B-4F62-A7A0-4A5AAB2E7B2AQ38387351-85FF22D3-E567-48A9-8F1F-A4DF5CB5D879Q38428533-EF1EF490-D141-4796-9071-E6B92F8D7144Q38609742-2697FA92-4556-49CF-891A-397FAC7B5E58Q39077895-1DAADCB0-6787-493B-8B31-B89BEAFCD645Q39662399-E728DA41-DBD1-49AB-AF6A-45C7CA6B1D5DQ40105189-6F8384BD-14AB-456C-97DC-1CE300364110Q41145891-41E51E6B-39A9-449A-B647-CA7D56A2E0D6Q42135814-3224C497-5C21-4ADB-B8B2-99915A01966CQ42156585-D9D6F4F6-224E-4F88-89FD-AF58DFE2114AQ42635816-6A4F7486-002E-4637-B92F-C81DFEE25FAEQ43365011-2FC0E7DD-A4D3-4E61-AE7D-FE7AAEBD8984Q45165706-23AC2D9C-BBEF-46B8-AF3C-0D7833D68506Q47253086-85179837-EC87-4050-80B5-6D33A9FBF4A6
P2860
The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@ast
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@en
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@nl
type
label
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@ast
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@en
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@nl
prefLabel
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@ast
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@en
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@nl
P2093
P2860
P50
P1476
The lessons of QUANTEC: recomm ...... ndencies of treatment outcome.
@en
P2093
Andrew Jackson
Ellen D Yorke
Lawrence B Marks
Louis S Constine
Randal K Ten Haken
P2860
P304
P356
10.1016/J.IJROBP.2009.08.074
P407
P433
P577
2010-03-01T00:00:00Z